Spots Global Cancer Trial Database for T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
Official Title: T-cell MRD Evaluation Using Flow Cytometric Analysis
Study ID: NCT01078337
Conditions
Study Description
Brief Summary: To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University School of Medicine, Stanford, California, United States
Contact Details
Name: Gary V Dahl
Affiliation: Stanford University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
